The implementation of PSMA imaging in prostate cancer (PC) management has significantly improved the medical care of patients owing to its clinical impact, particularly with respect to biochemical recurrence.
However, there is still an unmet clinical need regarding the correct discrimination of equivocal, centrally located, focal [
